academic@aribas.edu.in +91 2692 229189
CHARUTAR VIDYA MANDAL'S
ASHOK & RITA PATEL INSTITUTE OF INTEGRATED STUDY & RESEARCH IN BIOTECHNOLOGY AND ALLIED SCIENCES
ARIBAS - A Constituent College of CVM University, Vallabh Vidyanagar, Gujarat, India
Four Star College in Gujarat, KCG(GSIRF), Recognized under 2(f) and 12(B) of the UGC act, 1956
FACULTY PROFILE

Dr. Chandramani Pathak
Professor
CPathak@aribas.edu.in
M.Sc. Biotechnology,
Ph.D. (Biochemistry: Cancer Biology)

RESEARCH INTEREST

  • Cancer Biology, Programmed Cell death (apoptosis, autophagy & necrosis) Signaling in Cancer, Nanoparticle based Drug delivery, Oxidative stress, Pain & Inflammation, and Molecular basis of diseases i.e., Cancer, Sepsis, Diabetes, Osteoporosis etc.

HONOURS/AWARDS/GRANTS/CONSULTANCIES

  1. 2022 - INSO Outstanding Scientist Award
  2. 2017 - Excellence in Research Award
  3. 2011 - DST Young Scientist Award
  4. 2010 - DBT Rapid Grant for Young Investigator
  5. 2008 - Dr. D.S. Kothari, UGC Postdoctoral Fellowship Award
  6. 2004 - ICMR-Senior Research Fellowship Award

REPRESENTATION IN ACADEMIC & ADMINISTRATIVE BODIES

  1. Vice Chairman, Institutional Ethical Committee, Jay Research Foundation, Bapi, Gujarat (2021-Conti)
  2. Reviewer, SERB CRG grants, DST, Gov of India
  3. Member Secretory of DRP committee, AUH (2020-2022)
  4. Member of of Board of Studies, AIB, AUH (2020-2022)
  5. Chairmen of Board of Studies, IAR (2014-2019)
  6. Chairmen of Institutional purchase committee, IAR (2016-2019)
  7. Chairman of University student affairs committee, IAR (2014-2019)
  8. Member Secretary of Academic Council, IAR (2014-2019)
  9. Member of Board of Management & Governing body, (2014-2019)
  10. Member of Institutional Biological Safety Committee (IBSC), IAR (2012-2020)
  11. Member Secretary of Animal Ethical Committee, IAR (2012-2019)
  12. Member of University Finance Committee (2016-2019)
  13. Member of Institutional purchase committee, IAR (2012-2016)
  14. Member secretary of Board of Management, IAR (2013-2016)
  15. Member secretary of Board of Governor, IAR (2014-2015)
  16. Member secretary of Research Advisory committee, IAR (2012-2016)
  17. Member of PhD Regulatory Committee, IAR, (2014-2019)
  18. Member of PhD Guidance Committee, IAR (2014-2020)
  19. Member of Ph.D. Research Progress Committee, Nirma University, Ahmedabad
  20. External expert member of Animal ethical committee, NIOH, ICMR, Ahmedabad

MEMBER OF SCIENTIFIC SOCITIES

  1. Executive Committee & Life Member of Indian Society of Translation Research (2018-Conti)
  2. Executive Committee & Life Member of Society of Inflammation Research, India (2016- Conti)
  3. Executive Committee & Life Member of Indian Society of Cell Biology (2017-2019)
  4. Life member of Indian Academy of Biomedical Science
  5. Life member of Indian Society of Cell Biology.
  6. Life member of Society of Biological Chemist, India.
  7. Life member of Indian Association for Cancer Research
  8. Life member of Society for Free Radical Research, India
  9. Life member of Indian society of Chemists and Biologists.
  10. Life Member of Society of Mitochondrial Research & Medicine, India
  11. Life Member of Indian Society of Nanomedicine.
  12. Life Member of Biotechnology Research Society of India

EDITORIAL BOARD MEMBER

  1. Current Drug Metabolism
  2. Frontiers in Oncology
  3. Frontier in Cancer Genetics
  4. Mitochondrial DNA Part B-Resources
  5. International Journal of Immunology Research,
  6. Indian Journal of Pathology & Microbiology

PUBLICATIONS

  1. Rawat, S.G., Tiwari, R.K., Jaiswara, P.K., Gupta V.K., Sonker P., Vishvakarma N.K., Kumar S., Pathak C., Gautam V. & Kumar A. (2022) Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism. Apoptosis. https://doi.org/10.1007/s10495-022-01741-0 (Impact Factor: 4.6).
  2. Singh S., Kishore D., Singh R.K., Pathak C., Ranjan K. (2022) Higher BCG-induced trained immunity prevalence predicts protection from COVID-19: Implications for ongoing BCG trials. Clinical and Translational Discovery, https://doi.org/10.1002/ctd2.60
  3. Patel HS, Shaikh SJ, Ray D, Aswal VK, Vaidya F, Pathak C, Sharma RK. (2022) Formulation, Solubilization, and In Vitro Characterization of Quercetin-Incorporated Mixed Micelles of PEO-PPO-PEO Block Copolymers. Appl Biochem Biotechnol. doi: 10.1007/s12010-021-03691-w. (Impact Factor: 2.9).
  4. Varma R.R., Vaidya, F.U., Pathak, C., Dhaduk,M.P., Dabhi,R.A., Bhatt,B.S., & Patel,M.N. (2021) Synthesis, spectroscopic characterization, computational and biological evaluation of organometallic Re(I) complexes with 5-(2-butyl-5-chloro-1H-imidazol-4-yl)-1,3-diaryl- 4,5-dihydro-1H-pyrazole, Inorganic Chemistry Communications,109005, https://doi.org/10.1016/j.inoche.2021.109005. (Impact Factor: 2.5)
  5. Pansuriya, V. B., Kapadiya, K. M., Rathod, S. L., Prajapati, U. B., Vavaiya, B. M., Padariya, J. B., Vaidya, F. U., Pathak, C., & Parekh, H. M. (2021) "Anti-Cancer Activity of Gabapentin and Chiral Amino Acids-Based Hybrid-Peptides against MCF-7 Breast Cancer Cell-Line", Journal of Pharmaceutical Research International, 33(46A), 431-446. doi: 10.9734/jpri/2021/v33i46A32886 (Impact Factor: 5.5)
  6. Kanthecha, D. N., Bhatt, B. S., Patel, M. N., Vaidya, F. U., & Pathak, C. (2021). DNA interaction, anticancer, cytotoxicity and genotoxicity studies with potential pyrazine-bipyrazole dinuclear µ-oxo bridged au (III) complexes. Molecular Diversity, doi:10.1007/s11030-021-10317-0 Impact Factor: 2.9)
  7. Pursuwani, B. H., Bhatt, B. S., Raval, D. B., Thakkar, V. R., Sharma, J., Pathak, C., & Patel, M. N. (2021). Synthesis, characterization, and biological applications of pyrazole moiety bearing osmium (IV) complexes. Nucleosides, Nucleotides and Nucleic Acids, 40(6), 593-618. doi:10.1080/15257770.2021.1921795 (Impact Factor: 1.4)
  8. Parmar, M.P., Waghela B.N., Vaidya F.U., Pathak C., Parmar, D.V. (2021). "Evaluation of Antimitotic Activity of Herbal Extracts Using Plant-Based Model Systems and Their Cytotoxic Potential against Human Colon Carcinoma Cells", Journal of Cancer Research and Therapeutics, doi:10.4103/jcrt.JCRT_853_19. (Impact Factor: 1.8)
  9. Varma, R. R., Pandya, J. G., Vaidya, F. U., Pathak, C., Dabhi, R. A., Dhaduk, M. P., Bhatt, B.S., Patel, M. N. (2021). DNA interaction, anticancer, antibacterial, ROS and lipid peroxidation studies of quinoxaline-based organometallic re(I) carbonyls. Journal of Molecular Structure, 1240 doi:10.1016/j.molstruc.2021.130529 (Impact Factor: 3.2)
  10. Waghela, B. N., Vaidya, F. U., & Pathak, C. (2021). Upregulation of NOX-2 and Nrf-2 promotes 5-fluorouracil resistance of human colon carcinoma (HCT-116) cells. Biochemistry (Moscow), 86(3), 262-274. doi:10.1134/S0006297921030044 (Impact Factor: 2.5)
  11. Waghela, B. N., Vaidya, F. U., Agrawal, Y., Santra, M. K., Mishra, V., & Pathak, C. (2021). Molecular insights of NADPH oxidases and its pathological consequences. Cell Biochemistry and Function, 39(2), 218-234. doi:10.1002/cbf.3589. (Impact Factor: 3.6)
  12. Gandhi, D. H., Vaidya, F. U., Pathak, C., Patel, T. N., & Bhatt, B. S. (2021). Mechanistic insight of cell anti-proliferative activity of fluoroquinolone drug-based cu (II) complexes. Molecular Diversity, doi:10.1007/s11030-021-10199-2 (Impact Factor: 2.9)
  13. Pursuwani, B. H., Bhatt, B. S., Vaidya, F. U., Pathak, C., & Patel, M. N. (2021). Fluorescence, DNA interaction and cytotoxicity studies of 4,5-dihydro-1H-pyrazol-1-yl moiety based os (IV) compounds: Synthesis, characterization, and biological evaluation. Journal of Fluorescence, 31(2), 349-362. doi:10.1007/s10895-020-02657- (Impact Factor: 2.0)
  14. Varma, R. R., Pandya, J. G., Sharma, J., Pathak, C., & Patel, M. N. (2021). DNA interaction, in vivo and in vitro cytotoxicity, reactive oxygen species, lipid peroxidation of –N, S donor re(I) metal complexes. Molecular Diversity, 25(2), 687-699. doi:10.1007/s11030-020-10040-2. (Impact Factor: 2.9)
  15. Jaiswara, P. K., Gupta, V. K., Sonker, P., Rawat, S. G., Tiwari, R. K., Pathak, C., Kumar, S., Kumar, A. (2021). Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism. Environmental Toxicology, 36(4), 628-641. doi:10.1002/tox.23067 (Impact Factor: 4.1)
  16. Waghela, B. N., Vaidya, F. U., Ranjan, K., Chhipa, A. S., Tiwari, B. S., & Pathak, C. (2021). AGE-RAGE synergy influences programmed cell death signaling to promote cancer. Molecular and Cellular Biochemistry, 476(2), 585-598. doi:10.1007/s11010-020-03928-y. (Impact Factor: 3.4)
  17. Pursuwani, B. H., Bhatt, B. S., Vaidya, F. U., Pathak, C., & Patel, M. N. (2021). Tetrazolo[1,5-a] quinoline moiety-based os (IV) complexes: DNA binding/cleavage, bacteriostatic and photocytotoxicity assay. Journal of Biomolecular Structure and Dynamics, 39(8), 2894-2903. doi:10.1080/07391102.2020.1756912. (Impact Factor: 3.3)
  18. Bhatt, B. S., Gandhi, D. H., Vaidya, F. U., Pathak, C. , & Patel, T. N. (2021). Cell apoptosis induced by ciprofloxacin based cu(II) complexes: Cytotoxicity, SOD mimic and antibacterial studies. Journal of Biomolecular Structure and Dynamics, 39(12), 4555-4562. doi:10.1080/07391102.2020.1776641. (Impact Factor: 3.3)
  19. Ranjan, K., Waghela, B. N., Vaidya, F. U., & Pathak, C. (2020). Cell-penetrable peptide-conjugated FADD induces apoptosis and regulates inflammatory signaling in cancer cells. International Journal of Molecular Sciences, 21(18), 1-20. doi:10.3390/ijms21186890. (Impact Factor: 5.9)
  20. Vaidya, F. U., Sufiyan Chhipa, A., Mishra, V., Gupta, V. K., Rawat, S. G., Kumar, A., & Pathak, C. (2020). Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Reports, doi:10.1002/cnr2.1291 (Impact Factor: Awaiting)
  21. Pursuwani, B. H., Bhatt, B. S., Vaidya, F. U., Pathak, C., & Patel, M. N. (2020). Synthesis, characterization, and biological evaluation of osmium (IV) pyrazole carbothioamide complexes. Polycyclic Aromatic Compounds, doi:10.1080/10406638.2020.1852581. (Impact Factor: 1.8)
  22. Varma, R. R., Pandya, J. G., Vaidya, F. U., Pathak, C. , Bhatt, B. S., & Patel, M. N. (2020). Biological activities of pyrazoline-indole based re(I) carbonyls: DNA interaction, antibacterial, anticancer, ROS production, lipid peroxidation, in vivo and in vitro cytotoxicity studies. Chemico-Biological Interactions, 330 doi:10.1016/j.cbi.2020.109231. (Impact Factor: 5.1)
  23. Varma, R. R., Pandya, J. G., Vaidya, F. U., Pathak, C., Bhatt, B. S., & Patel, M. N. (2020). Synthesis, characterization, and biological application of pyrazolo[1,5-a]pyrimidine based organometallic re(I) complexes. Acta Chimica Slovenica, 67(3), 957-969. doi:10.17344/acsi.2020.6017 (Impact Factor: 1.7)
  24. Waghela B.N., Vaidya F.U., Gaurav Dave, & Pathak C., (2020). Inhibition of NADPH oxidase activity augments 5-fluorouracil mediated cell Death in human colon carcinoma cells, Int. J. Adv. Res. 8(07), 865-874.
  25. Priyadarshi, K., Shirsath, K., Waghela, N. B., Sharma, A., Kumar, A., & Pathak, C. (2020). Surface modified PAMAM Dendrimers with Gallic acid inhibits, cell proliferation cell migration and inflammatory response to augments apoptotic cell death in human colon carcinoma cells. Journal of Biomolecular Structure & Dynamics, https://doi.org/10.1080/07391102.2020.1802344 (Impact Factor: 3.3)
  26. Patel, N. J., Bhatt, B. S., Vekariya, P. A., Vaidya, F. U., Pathak, C., Pandya, J., & Patel, M. N. (2020). Synthesis, characterization, structural-activity relationship, and biomolecular interaction studies of heteroleptic pd (II) complexes with acetyl pyridine scaffold. Journal of Molecular Structure, 1221 doi:10.1016/j.molstruc.2020.128802 (Impact Factor: 3.2)
  27. Pursuwani, B. H., Bhatt, B. S., Vaidya, F. U., Pathak, C., & Patel, M. N. (2020). Oxadiazole based os(IV) compounds as potential DNA intercalator and cytotoxic agents. Inorganic Chemistry Communications, 119 doi:10.1016/j.inoche.2020.108070 (Impact Factor: 2.5)
  28. Doshi, P., Bhargava, P., Singh, V., Pathak, C., Joshi, C., & Joshi, M. (2020). Escherichia coli strain engineering for enhanced production of serratiopeptidase for therapeutic applications. International Journal of Biological Macromolecules, 160, 1050-1060. doi:10.1016/j.ijbiomac.2020.05.256 (Impact Factor: 6.9)
  29. Kanthecha, D. N., Bhatt, B. S., Patel, M. N., Raval, D. B., Thakkar, V. R., Vaidya, F. U., & Pathak, C. (2020). Bipyrazole based novel bimetallic µ-oxo bridged au (III) complexes as potent DNA interacalative, genotoxic, anticancer, antibacterial, and cytotoxic agents. Journal of Inorganic and Organometallic Polymers and Materials, 30(12), 5085-5099. doi:10.1007/s10904-020-01618-2 (Impact Factor: 3.5)
  30. Rao, T.S., Mustfa, S.A., Pathak, C., & Ranjan, K. (2019). Cancer Immunotherapy: Future prospective with wide therapeutic spectrum. Cancer Sci Res Open Access 6(2): 1-8. DOI: 10.15226/csroa.2019.00153
  31. Kulkarni P.G., Shah N., Waghela B.N., Pathak C.M., Pappachan A. (2019) Leishmania donovani adenylate kinase 2a prevents ATP-mediated cell cytolysis in macrophages. Parasitology International. 72:101929 https://doi.org/10.1016/j.parint.2019.101929 (Impact Factor: 3.9)
  32. Manglani, K., Vijayan, V., Pathak, C., Khandelwal, M., Singh, P., Chellappa, S., Yadav, V.K., Surolia, A., Gupta, S. (2019). Development and characterization of supramolecular calcitonin assembly and assessment of its interactions with the bone remodelling process. Bone, 122, 123-135. doi:10.1016/j.bone.2019.02.019 (Impact Factor: 4.2)
  33. Mishra, V., & Pathak, C. (2019). Human toll-like receptor 4 (hTLR4): Structural and functional dynamics in cancer. International Journal of Biological Macromolecules, 122, 425-451. doi:10.1016/j.ijbiomac.2018.10.142 (Impact Factor: 6.9)
  34. Vaidya, F. U., Sharma, R., Shaikh, S., Ray, D., Aswal, V. K., & Pathak, C. (2019). Pluronic micelles encapsulated Curcumin manifests apoptotic cell death and inhibits pro-inflammatory cytokines in Human breast adenocarcinoma cells. Cancer Reports, 2:1-e1133. https://doi.org/10.1002/cnr2.1133 (Impact Factor: Awaiting)
  35. Mishra, V., & Pathak, C. (2019). Structural insights into pharmacophore assisted in silico identification of protein-protein interaction inhibitors for inhibition of human Toll-like receptor 4 – myeloid differentiation factor-2 (hTLR4−MD-2) complex. Journal of Biomolecular Structure and Dynamics. 37:1968-1991 DOI: 10.1080/07391102.2018.1474804 (Impact Factor: 3.3)
  36. Patel, S., Waghela, B., Shah, K., Vaidya, F., Mirza, S., Patel, S., Pathak C., & Rawal, R. (2018). Silibinin, A Natural Blend in Polytherapy Formulation for Targeting Cd44v6 Expressing Colon Cancer Stem Cells. Nature Scientific Reports, 8(1):16985 doi:10.1038/s41598-018-35069-0 (Impact Factor: 4.3)
  37. Pandey, S. S., Singh, S., Pathak, C., & Tiwari, B. S. (2018). Programmed Cell Death: A Process of Death for Survival" – How Far Terminology Pertinent for Cell Death in Unicellular Organisms. Journal of Cell Death, 11:1-4 doi:10.1177/1179066018790259
  38. Lunagariya, M. V., Thakor, K. P., Waghela, B. N., Pathak, C., & Patel, M. N. (2018). Design, synthesis, pharmacological evaluation, and DNA interaction studies of binuclear pt (II) complexes with pyrazolo[1,5-a]pyrimidine scaffold. Applied Organometallic Chemistry, 3232 (4) e4222 doi:10.1002/aoc.4222 (Impact Factor: 4.1)
  39. Lunagariya, M. V., Thakor, K. P., Varma, R. R., Waghela, B. N., Pathak, C., & Patel, M. N. (2018). Synthesis, characterization, and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum (II) complexes. MedChemComm, 9(2), 282-298. doi:10.1039/c7md00472a (Impact Factor: 2.4)
  40. Lunagariya, M. V., Thakor, K. P., Waghela, B. N., Vaidya, F. U., Pathak, C., & Patel, M. N. (2018). Design, synthesis, MTT assay, DNA interaction studies of platinum (II) complexes. Journal of Biomolecular Structure and Dynamics, 36(1), 14-31. doi:10.1080/07391102.2016.1268071 (Impact Factor: 3.3)
  41. Kumar, M., Ranjan, K., Singh, V., Pathak, C., Pappachan, A., & Singh, D. D. (2017). Hydrophilic Acylated Surface Protein A (HASPA) of Leishmania donovani: Expression, purification, and Biophysico-Chemical Characterization. Protein J. 36(4):343-351, doi 10.1007/s10930-017-9726-x (Impact Factor: 2.3)
  42. Ranjan, K., & Pathak, C. (2016). Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death. Molecular Cellular Biochemistry 422(1-2):135-150, doi:10.1007/s11010-016-2813-z (Impact Factor: 3.4)
  43. Ranjan, K., & Pathak, C. (2016). FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Scientific Reports. 6:22787 doi:10.1038/srep22787. (Impact Factor: 4.3)
  44. Ranjan, K., & Pathak, C. (2016). Expression of cFLIPL determines the basal interaction of Bcl-2 with Beclin-1 and regulates p53 dependent ubiquitination of Beclin-1 during autophagic stress. Journal of Cellular Biochemistry, 117(8):1757-1768. doi:10.1002/jcb.25474 (Impact Factor: 4.4)
  45. Dhumale, S. S., Waghela, B. N., & Pathak, C. (2015). Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. IUBMB Life, 67(5):361-73, doi:10.1002/iub.1379(Impact Factor: 3.9)
  46. Waghela, B. N., Sharma, A., Dhumale, S., Pandey, S. M., & Pathak, C. (2015). Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity, and apoptosis in human colon carcinoma cells. PLoS ONE, 10(2) e0117526. doi:10.1371/journal.pone.0117526 (Impact Factor: 3.2)
  47. Pathak, C., Ranjan Singh, R., Yadav, S., Kapoor, N., Raina, V., Gupta, S., & Surolia, A. (2014). Evaluation of Benzothiophene carboxamides as analgesics and anti-inflammatory agents. IUBMB Life, 66(3), 201-211. doi:10.1002/iub.1252 (Impact Factor: 3.9)
  48. Ranjan, K., Sharma, A., Surolia, A., & Pathak, C. (2014). Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells. BioFactors, 40(1), 157-169. doi:10.1002/biof.1098 (Impact Factor: 6.1)
  49. Ranjan, K., Surolia, A., & Pathak, C. (2012). Apoptotic potential of Fas-associated death domain on regulation of cell death regulatory protein cFLIP and death receptor mediated apoptosis in HEK 293T cells. Journal of Cell Communication and Signaling, 6(3), 155-168. doi:10.1007/s12079-012-0166-2 (Impact Factor: 5.8)
  50. Vinayak, M., & Pathak, C. (2010). Queuosine modification of tRNA: Its divergent role in cellular machinery. Bioscience Reports, 30(2), 135-148. doi:10.1042/bsr20090057
  51. Pathak, C., Jaiswal, Y. K., & Vinayak, M. (2008). Queuine promotes antioxidant defence system by activating cellular antioxidant enzyme activities in cancer. Bioscience Reports, 28(2), 73-81. doi:10.1042/BSR20070011 (Impact Factor: 3.8)
  52. Pathak, C., Jaiswal, Y. K., & Vinayak, M. (2008). Modulation in the activity of lactate dehydrogenase and level of c-myc and c-fos by modified base queuine in cancer. Cancer Biology and Therapy, 7(1), 85-91. doi:10.4161/cbt.7.1.5133 (Impact Factor: 4.7)
  53. Pathak, C., Jaiswal, Y. K., & Vinayak, M. (2008). Queuine mediated inhibition in phosphorylation of tyrosine phosphoproteins in cancer. Molecular Biology Reports, 35(3), 369-374. doi:10.1007/s11033-007-9095-1 (Impact Factor: 2.3)
  54. Pathak, C., Jaiswal, Y. K., & Vinayak, M. (2007). Possible involvement of queuine in regulation of cell proliferation. BioFactors, 29(4), 159-173. doi:10.1002/biof.5520290401. (Impact Factor: 6.1)
  55. Pathak, C., Jaiswal, Y. K., & Vinayak, M. (2005). Hypomodification of transfer RNA in cancer with respect to queuosine. RNA Biology, 2(4), 143-148. doi:10.4161/rna.2.4.2417 (Impact Factor: 5.3)
  56. Pathak, C., & Vinayak, M. (2005). Modulation of lactate dehydrogenase isozymes by modified base queuine. Molecular Biology Reports, 32(3), 191-196. doi:10.1007/s11033-004-6941-2. (Impact Factor: 2.3)

BOOKS/BOOK CHAPTERS

  1. Pathak C., Vaidya F.U., Waghela B.N., Chhipa A.S., Tiwari, B.S. & Ranjan K. (2021) Advanced glycation end products mediated oxidative stress and regulated cell death signalling in cancer; Sajal Chakrborty (Eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 1-16, Springer-Nature, DOI: 10.1007/978-981-15-4501-6_44-1, ISBN 978-981-15-4501-6
  2. Vaidya F.U., Chhipa A.S., Sagar N., Pathak C. (2020) Oxidative Stress and Inflammation Can Fuel Cancer. In: Maurya P., Dua K. (eds) Role of Oxidative Stress in Pathophysiology of Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-1568-2_14. ISBN: 978-981-15-1567-5
  3. Pathak C, Vaidya F.U. & Pandey, S.M. (2019) Mechanism for Development of Nanobased Drug Delivery System. In Mohapatra et al. (Eds) Applications of Targeted Nano Drugs and Delivery Systems Nanoscience and Nanotechnology in Drug Delivery: A volume in Micro and Nano Technologies. Elsevier, https://doi.org/10.1016/C2017-0-00274-4; ISBN 978-0-12-814029-1.
  4. Maurya, V. K., Kumar, D., Pathak, C., & Tiwari, B. S. (2018) Involvement of Reactive Species of Oxygen and Nitrogen in Triggering Programmed Cell Death in Plants. In: Vats S. (eds) Biotic and Abiotic Stress Tolerance in Plants. pp. 257-278, Springer, Singapore https://doi.org/10.1007/978-981-10-9029-5_10 ISBN 978-981-10-9028-8
  5. Sharma R.K. & Pathak C. (2014). A Novel Lamotrigine-Loaded Nanoparticles using PEO-PPO-PEO Tri-block Copolymers. Nanotechnology: Novel Perspectives and Prospects. McGrew Hill, New Delhi; 898-906 ISBN: 13:978-93-392-2109-6

PRESEANTATIONS

National 24
International 40

PROJECTS

Completed 06
On Going --

PH. D. GUIDED

Completed 05
On Going --

M. SC. DISSERTATION GUIDED

Completed 33
On Going --